Additionally, we assessed the frequency of PALB2 P/LP variants in the gnomAD non-cancer cohort, which showed similar detection ratios in comparison to our cancer control groups (non-HBOC phenotype) (Table 4). The gene discussed is PALB2; the disease is cancer.